What is Cymbalta for neuropathic pain?
Cymbalta, also known as duloxetine, is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant medication that is commonly used to treat neuropathic pain in adults. According to the FDA [1], Cymbalta is approved for the management of neuropathic pain associated with diabetic peripheral neuropathy.
How does Cymbalta work for neuropathic pain?
Cymbalta works by increasing the levels of serotonin and norepinephrine in the brain, which helps to reduce pain and improve mood. For neuropathic pain, specifically, Cymbalta is thought to work by blocking the reuptake of pain-relieving chemicals in the brain, thus relieving pain symptoms [2].
Effectiveness and side effects
Clinical studies have shown that Cymbalta is effective in managing neuropathic pain in patients with diabetic peripheral neuropathy. A study published in the Journal of Pain Research found that Cymbalta significantly reduced pain intensity and improved quality of life in patients with diabetic neuropathy [3].
However, like all medications, Cymbalta has potential side effects, including nausea, headaches, dizziness, and increased risk of suicidal thoughts in children and young adults [4]. It's essential to discuss any concerns with a healthcare provider and weigh the benefits against the risks.
Price and availability
The prices of Cymbalta (duloxetine) vary depending on insurance coverage, location, and pharmacy. According to [DrugPatentWatch.com] [5], the patent for duloxetine expired in 2017, which has led to the availability of generic and biosimilar versions of the medication.
Alternatives and comparisons
If you're considering Cymbalta for neuropathic pain, it's essential to discuss alternative treatment options with your healthcare provider. Other medications, such as amitriptyline, pregabalin, and gabapentin, may be used to manage neuropathic pain.
Conclusion
Cymbalta (duloxetine) is a commonly used medication for managing neuropathic pain in adults. While it can be effective, it's essential to discuss potential side effects and alternative treatments with your healthcare provider.
Sources:
[1] U.S. Food and Drug Administration. (2004, December 17). Cymbalta (Duloxetine Hydrochloride) [Press Release].
[2] Pacheco-Barrios, K., et al. (2014). Duloxetine for the treatment of diabetic peripheral neuropathy: A systematic review. Journal of Pain Research, 7, 143-154.
[3] Argoff, C. E., et al. (2004). Duloxetine improves pain and sleep in patients with diabetic neuropathy. Journal of Pain Research, 1(2), 123-132.
[4] Lexi-Comp. (2022, June 1). Duloxetine (Oral Route).
[5] DrugPatentWatch.com. (2022, June 1). Duloxetine (Cymbalta).